scholarly journals Reduced survival motor neuron (Smn) gene dose in mice leads to motor neuron degeneration: an animal model for spinal muscular atrophy type III

2000 ◽  
Vol 9 (3) ◽  
pp. 341-346 ◽  
Author(s):  
S. Jablonka
Brain ◽  
2019 ◽  
Vol 143 (1) ◽  
pp. 2-5
Author(s):  
Niko Hensel ◽  
Nora Tula Detering ◽  
Lisa Marie Walter ◽  
Peter Claus

This scientific commentary refers to ‘ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy’, by Kannan et al. (doi: 10.1093/brain/awz373).


Cell Reports ◽  
2017 ◽  
Vol 21 (13) ◽  
pp. 3767-3780 ◽  
Author(s):  
Christian M. Simon ◽  
Ya Dai ◽  
Meaghan Van Alstyne ◽  
Charalampia Koutsioumpa ◽  
John G. Pagiazitis ◽  
...  

2011 ◽  
Vol 192 (3) ◽  
pp. 481-495 ◽  
Author(s):  
Anindya Sen ◽  
Takakazu Yokokura ◽  
Mark W. Kankel ◽  
Douglas N. Dimlich ◽  
Jan Manent ◽  
...  

Spinal muscular atrophy (SMA), a devastating neurodegenerative disorder characterized by motor neuron loss and muscle atrophy, has been linked to mutations in the Survival Motor Neuron (SMN) gene. Based on an SMA model we developed in Drosophila, which displays features that are analogous to the human pathology and vertebrate SMA models, we functionally linked the fibroblast growth factor (FGF) signaling pathway to the Drosophila homologue of SMN, Smn. Here, we characterize this relationship and demonstrate that Smn activity regulates the expression of FGF signaling components and thus FGF signaling. Furthermore, we show that alterations in FGF signaling activity are able to modify the neuromuscular junction defects caused by loss of Smn function and that muscle-specific activation of FGF is sufficient to rescue Smn-associated abnormalities.


2021 ◽  
Vol 12 (01) ◽  
pp. 210-212
Author(s):  
Divya M. Radhakrishnan ◽  
Ritu Shree ◽  
Govind Madhaw ◽  
Rajat Manchanda ◽  
Anita Mahadevan ◽  
...  

AbstractThe association of spinal muscular atrophy (SMA) with progressive myoclonic epilepsy, also known as “SMA plus,” is a unique syndrome linked to non-survival motor neuron (non-SMN) genes. The disease starts in childhood with progressive weakness and atrophy of muscles; myoclonic epilepsy develops during later childhood, after the onset of motor symptoms. In this report, we describe a case of SMN gene unrelated SMA and myoclonic epilepsy, supported by electrophysiological and neuropathological evidences.


2020 ◽  
Vol 8 (1) ◽  
Author(s):  
Catherine Elizabeth Pringle ◽  
Robert Nelson ◽  
Willie Miller ◽  
Rashmi Kothary ◽  
Jean Michaud

Abstract Spinal muscular atrophy (SMA) is largely linked to deletion or mutation of the Survival motor neuron 1 (SMN1) gene located on chromosome 5q13. Type III (Kugelberg–Welander disease) is the mildest childhood form and patients may become ambulatory and have a normal life expectancy. We report the clinical history and morphological findings of a 55-year-old woman who began to experience motor problems at the age of two. She was never fully ambulatory, and her severe scoliosis required the insertion of surgical rod at age 19. Unexpectedly, around 35 years of age, she began to experience sensory symptoms best characterized as a myelo-radiculo-neuropathy with pain as the dominant symptom. Investigations never clarified the etiology of these symptoms. Molecular confirmation of SMA type III was done post-mortem. Neuropathological examination showed classic changes of lower motor neuron neurodegeneration, in line with those reported in the single molecularly confirmed case published so far, and with findings in rare cases reported prior to the discovery of the gene defect. A key autopsy finding was the presence of a severe superficial siderosis of the lower half of the spinal cord. In recent years, the concept of duropathy was put forward, associating superficial siderosis of the spinal cord with various spinal abnormalities, some of which were present in our patient. The presence of significant hemosiderin deposits in the spinal cord and sensory nerve roots with associated tissue and axonal damage provide a plausible explanation for the unexpected sensory symptomatology in this mild lower motor neurodegeneration.


Sign in / Sign up

Export Citation Format

Share Document